Cell Counting Market - Expected to Reach $1.7 Billion by 2025 - Research and Markets Print
Business Wire
Monday, 02 October 2017 04:06
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Biotechnology
Oct. 2, 2017 14:06 UTC

Cell Counting Market - Expected to Reach $1.7 Billion by 2025 - Research and Markets

DUBLIN--(BUSINESS WIRE)-- The "Cell Counting Market, 2014-2025" report has been added to Research and Markets' offering.

The global cell counting market is expected to reach USD 1.7 billion by 2025.

Government initiatives working to promote development of cell therapeutics, wherein cell counting plays an imperative role, is expanding growth prospects for the

Error. Page cannot be displayed. Please contact your service provider for more details. (20)

market. As a result of extensive R&D activities, the number of diseases treated with the
help of stem cells increased to 82 in 2016 from 27 in 2005. Also, California Institute for Regenerative Medicine's funding of USD 271 million for stem cell therapy created 12 R&D facilities in California, and these facilities brought approximately USD 543 million funding. In addition, it is also funded by National Institutes of Health (NIH), which approximately invested USD 1,429 million in 2015.

Increase in the number of collaborations of research institutes with various public and private entities to promote R&D has provided significant boost to the market. Growing number of proposed guidelines and recommendations for public and private laboratories to ensure high-quality standards and facilitate generation of accurate results are likely to improve adoption of instruments over the coming years. For instance, in May 2016, the International Society for Stem Cell Research updated guidelines for the development of cell-based therapy and research. The proposed guidelines focus on all stages of R&D and improve quality of preclinical studies.

Companies Mentioned

  • Thermo Fisher Scientific, Inc.
  • Merck KGaA
  • Agilent Technologies
  • PerkinElmer, Inc.
  • BD
  • Danaher
  • Bio-Rad Laboratories, Inc.
  • BioTek Instruments, Inc.
  • GE Healthcare

Key Topics Covered:

Chapter 1 Research Methodology & Scope

Chapter 2 Executive Summary

Chapter 3 Cell Counting Market Variables, Trends & Scope

Chapter 4 Cell Counting Market: Product Estimates & Trend Analysis

Chapter 5 Cell Counting Market: End-use Estimates & Trend Analysis

Chapter 6 Cell Counting Market: Regional Estimates & Trend Analysis, by Product, End Use

Chapter 7 Competitive Landscape

For more information about this report visit https://www.researchandmarkets.com/research/sprj39/cell_counting

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Biotechnology


Source: Research and Markets




BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and
firms. Full disclosures should be read in the 'About Us Section'.

Add this page to your favorite Social Bookmarking websites
Digg! Reddit! Del.icio.us! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!
  BMR:1